Earlier oestrogen exposure can transiently intensify oestrogen‐responsive enhancers (e.g., at IL2RA, FOXP3), potentially tipping borderline‐risk girls into clinical diabetes in regions where childhood incidence is still low,90 though longitudinal studies directly linking pubertal timing to T1D onset are lacking. The gene discussed is FOXP3; the disease is type 1 diabetes mellitus.